2,649 results on '"Zinman B."'
Search Results
2. The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes
3. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia
4. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
5. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
6. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications
7. Lower dietary vitamin E intake during the second trimester is associated with insulin resistance and hyperglycemia later in pregnancy
8. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
9. Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers
10. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones
11. Determination and kinetic analysis of non-insulin mediated glucose uptake in Type 1 (insulin-dependent) diabetes mellitus
12. The metabolic and hormonal responses to a mixed meal in umestrained pancreatectomised dogs chronically treated by portal or peripheral insulin infusion
13. Blood glucose control and insulin clearance in unrestrained diabetic dogs portally infused with a portable insulin delivery system
14. The metabolic and hormonal responses to glucose infusion in anaesthetized normal and diabetic dogs controlled by an artificial B-cell
15. Optimal glycaemic control in unrestrained diabetic dogs using programmed compound squarewave insulin infusions
16. Exercise and diabetes
17. High Serum Zinc Concentration Accelerates Progression of Isolated Impaired Glucose Tolerance to Type 2 Diabetes: A Cohort Study: High Serum Zinc Concentration Accelerates Progression of Isolated Impaired Glucose Tolerance to Type 2 Diabetes: A Cohort Study
18. Dose-Dependent Relationship Between Long-Term Metformin Use and the Risk of Diabetic Retinopathy: A Population-Based Cohort Study: Metformin and Diabetic Retinopathy
19. Relationship between new-onset proteinuria and the volume of the non-donated kidney before and after donation in living kidney donors
20. Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies: Drug Development in Pediatric Chronic Kidney Disease
21. Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes: Die Kernpunkte der Leitlinien
22. Use of Cardioprotective Adjuncts in Type 1 Diabetes
23. A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants
24. Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study
25. Ex Vivo Human Tissue Functions as a Testing Platform for the Evaluation of a Nerve-Specific Fluorophore
26. Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis
27. Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients—A Narrative Review: Euglycemic Ketoacidosis in Non-diabetics
28. The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression
29. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
30. Effect of oral semaglutide on remnant-like lipoprotein cholesterol in patients with ischemic heart disease receiving statin therapy
31. Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring: ACUTE LYMPHOBLASTIC LEUKEMIA
32. Medical nutrition therapy in physiological pregnancy and in pregnancy complicated by obesity and/or diabetes: SID-AMD recommendations
33. Empagliflozin Reduces High Glucose-Induced Cardiomyopathy in hiPSC-Derived Cardiomyocytes: Glucose-induced Lipotoxicity in hiPSC-Derived Cardiomyocytes
34. Glomerular diameter is associated with a reduction in urinary protein by treatment with dapagliflozin in patients with chronic kidney disease
35. Untreated women with first trimester fasting glycaemia 92−125 mg/dL and risk of gestational diabetes mellitus in the 24−28th week OGTT: prevalence and predictors
36. Glucagon-like peptide 1 receptor agonists outperform basal insulin in cardiovascular and renal outcomes for type 2 diabetes mellitus: a retrospective cohort study
37. Diabetes im Krankenhaus
38. Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches
39. Long-term efficacy and safety of early sitagliptin initiation in individuals with type 2 diabetes: an extension of the SPIKE study: Long-term efficacy and safety of early sitagliptin initiation
40. Comparative Efficacy and Safety of Oral Semaglutide in Asians and Non-Asians Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
41. Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease
42. Commentary on the Donovan Memorial Lecture: Addiction and Recovery as a Continuum
43. Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
44. Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics
45. Tofogliflozin reduces sleep apnea severity in patients with type 2 diabetes mellitus and heart failure: a prospective study
46. Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
47. Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013–2019
48. Changing the paradigm in heart failure: shifting from treatment to prevention
49. Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function
50. Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.